NuVasive Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to NuVasive Reports Second Quarter 2017 Financial Results
July 27, 2017 5:17 PM EDT
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced a new organizational structure to drive the Company's growth and profitability goals, supporting its strategy to help deliver safer, more predictable spine surgery.
"As the innovation pioneer and largest, pure-play spine technology company, NuVasive continues to deliver significant value to its customers and shareholders," said Gregory T. Lucier, NuVasive's chairman and chief executive officer. "With incredible opportunities ahead, we are taking steps to refine the company's operating structure to tightly align strategy,... More
July 27, 2017 4:49 PM EDT
NuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.46, $0.02 better than the analyst estimate of $0.44. Revenue for the quarter came in at $260.6 million versus the consensus estimate of $262.22 million.
For earnings history and earnings-related data on NuVasive (NUVA) click here.
...
More
